Clinical trial
GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients
NCT00291356 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00291356 |
|---|---|
| Title | GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients |
| Official title | A Double-blind, Randomized, Placebo-controlled, Repeat Dose Study to Compare the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK189075 With GW869682 in Subjects With Type 2 Diabetes Mellitus |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2, Non-Insulin-Dependent Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | GSK189075 oral tablets, GW869682 oral tablets |
| Enrollment | 45 |
| Start date | Jan 1, 2006 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Feb 14, 2006 |
| Last update posted | Apr 15, 2015 |
| Countries | Germany, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: